Efficacy of the twin-block appliance for pediatric obstructive sleep apnea: an updated systematic review and meta-analysis Authors: Xu Zhou, Feifei Wang, Maolin Fan, Dan Yang, Zhifeng Chen, Chunbo Hao Published: 2026 ABSTRACT AbstractObjectiveTo provide an updated and robust assessment of the efficacy of the Twin-Block appliance in the treatment of pediatric obstructive sleep apnea (OSA). A previous meta-analysis indicated a potential benefit, but was limited by the quality of available evidence and is now outdated. This study aims to synthesize all current evidence, including recent high-quality randomized controlled trials (RCTs).MethodsThis systematic review and meta-analysis was conducted following PRISMA guidelines. A comprehensive search of PubMed, Embase, Cochrane Library, and Web of Science was performed up to October 2025. We included RCTs, non-randomized controlled trials (NRCTs), and case series evaluating the effect of the Twin-Block appliance on respiratory parameters in children (< 18 years) with OSA. The primary outcome was the change in the Apnea-Hypopnea Index (AHI). A random-effects model was used to calculate the pooled Mean Difference (MD) and 95% Confidence Intervals (CIs). Sensitivity analyses were performed, and the risk of bias was assessed using design-specific tools (RoB 2, ROBINS-I, and the JBI Critical Appraisal Checklist).ResultsEight studies, comprising a total of 259 patients, were included in the systematic review. The meta-analysis of seven studies (n = 219) demonstrated that Twin-Block therapy resulted in a statistically significant and clinically meaningful reduction in AHI (pooled MD: -6.68, 95% CI: -8.76 to -4.60; p < 0.0001). Significant heterogeneity was observed across studies (I² = 89.1%). A recent high-quality RCT, while not poolable due to a different outcome measure, provided mechanistic evidence by showing a significant increase in oropharyngeal airway volume with Twin-Block treatment compared to a control group. The findings remained robust in sensitivity and leave-one-out analyses.ConclusionThis updated meta-analysis provides strengthened evidence that the Twin-Block appliance is an effective treatment for reducing the severity of OSA in appropriately selected children. The therapeutic effect is likely mediated by structural enlargement of the upper airway. Despite the heterogeneity and limitations in the primary literature, these findings support the consideration of the Twin-Block appliance as a viable non-surgical intervention for pediatric OSA, particularly in patients with mandibular retrognathia. Future large-scale RCTs are warranted to confirm these findings and establish long-term effectiveness.Supplementary InformationThe online version contains supplementary material available at 10.1007/s11325-026-03670-7.Keywords: Obstructive sleep apnea, Twin-block appliance, Pediatric, Mandibular advancement, Systematic review, Meta-analysis Introduction The clinical problem: pediatric OSA beyond adenotonsillar hypertrophy Pediatric Obstructive Sleep Apnea (OSA) is a significant public health concern, manifesting as a spectrum of sleep-disordered breathing that adversely impacts neurocognition, cardiometabolic health, and behavior in developing children [1]. Historically, the therapeutic paradigm for pediatric OSA has been dominated by adenotonsillectomy (T&A), predicated on the high prevalence of lymphoid tissue hypertrophy in this population [2, 3]. However, a substantial body of evidence now indicates that a considerable proportion of children experience persistent OSA post-T&A, suggesting that underlying craniofacial discrepancies are a critical, often primary, etiological factor [4]. Among these, skeletal Class II malocclusion characterized by mandibular retrognathia is a well-established anatomical endotype, predisposing children to a narrowed retrolingual airway and increased pharyngeal collapsibility [5, 6]. This highlights a critical need for effective therapeutic strategies that address these fundamental structural deficits. A mechanistic solution: mandibular advancement with the twin-block appliance Functional orthopedic appliances, designed to modify craniofacial growth, represent a mechanistically targeted intervention for this OSA subtype. The Twin-Block appliance, a widely utilized functional appliance, is engineered to stimulate mandibular growth and facilitate a more anterior positioning of the mandible [7]. Its efficacy in correcting skeletal Class II malocclusion is supported by robust evidence from the orthodontic field, including landmark multicenter randomized controlled trials [8–10]. The therapeutic rationale for its application in OSA is compelling, as mandibular advancement directly counteracts the retrolingual airway narrowing that is a key anatomical basis of obstruction in many children with OSA [11, 12]. By advancing the mandible, the Twin-Block concomitantly advances the tongue and associated soft tissues [13], thereby structurally enlarging the pharyngeal airway [14]. This proposed mechanism directly counteracts the anatomical basis of obstruction in children with mandibular retrognathia. Synthesizing the evidence: the need for an updated and methodologically rigorous review The translation of this orthodontic tool into the realm of sleep medicine has prompted numerous clinical investigations. A foundational systematic review and meta-analysis by Duan et al. [15] first synthesized this body of evidence, concluding that Twin-Block therapy was associated with a significant reduction in the Apnea-Hypopnea Index (AHI) [16]. While this was a crucial first step, the review’s conclusions were tempered by significant methodological limitations inherent in the primary literature available at the time. The analysis was heavily reliant on non-randomized studies, including a large proportion of case series, which carry a high intrinsic risk of bias. With only a single randomized controlled trial (RCT) included, the overall strength of the evidence was limited, and the observed high inter-study heterogeneity warranted cautious interpretation. Rationale and objectives Since the last synthesis, the evidence landscape has evolved [17]. Notably, the publication of new, methodologically rigorous RCTs provides a critical opportunity to re-evaluate this topic with a higher degree of certainty. An updated review is therefore imperative to consolidate this new evidence with the existing literature. The primary objective of this systematic review and meta-analysis was to provide an updated and comprehensive assessment of the efficacy of the Twin-Block appliance in treating pediatric OSA. Specifically, we aimed to: (1) determine the pooled effect estimate for the change in AHI based on all available evidence; (2) qualitatively compare the evidence derived from high-quality RCTs versus non-randomized studies; and (3) critically appraise the current body of literature to inform clinical practice and guide the design of future research. Methods Protocol and registration This systematic review and meta-analysis was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement [18]. The protocol for this review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) under the registration number CRD420251178172. Eligibility criteria Studies were included if they met the following criteria based on the PICO framework: (P)opulation: Children and adolescents (age < 18 years) with a diagnosis of obstructive sleep apnea (OSA) or sleep-disordered breathing (SDB). (P)opulation: Children and adolescents (age < 18 years) with a diagnosis of obstructive sleep apnea (OSA) or sleep-disordered breathing (SDB). (I)ntervention: Treatment with a Twin-Block or modified Twin-Block appliance. (I)ntervention: Treatment with a Twin-Block or modified Twin-Block appliance. (C)omparison: A control group (placebo, no treatment, or another active treatment) or a pre–post treatment design. (C)omparison: A control group (placebo, no treatment, or another active treatment) or a pre–post treatment design. (O)utcomes: Reported quantitative changes in at least one of the following respiratory parameters: Apnea-Hypopnea Index (AHI), Oxygen Desaturation Index (ODI), or pharyngeal airway dimensions. (O)utcomes: Reported quantitative changes in at least one of the following respiratory parameters: Apnea-Hypopnea Index (AHI), Oxygen Desaturation Index (ODI), or pharyngeal airway dimensions. (S)tudy Design: Randomized controlled trials (RCTs), non-randomized controlled trials (NRCTs), and case series. (S)tudy Design: Randomized controlled trials (RCTs), non-randomized controlled trials (NRCTs), and case series. Information sources and search strategy A comprehensive literature search was conducted in the following electronic databases from their inception to October 2025: PubMed, Embase, Cochrane Library, and Web of Science. The search strategy combined MeSH terms and keywords related to “Obstructive Sleep Apnea,” “Twin-Block,” and “Children” (e.g., (“Sleep Apnea, Obstructive“[Mesh] OR “OSA”) AND (“Twin-Block”) AND (“Child“[Mesh] OR “Pediatrics”)). No language restrictions were applied. The reference lists of included studies and relevant reviews were also manually screened for additional eligible publications. Selection process and data extraction Two reviewers independently screened the titles and abstracts of the retrieved records for potential eligibility. The full texts of the selected articles were then assessed against the inclusion criteria. Any disagreements were resolved through discussion with a third reviewer. Data were extracted independently by two reviewers using a standardized data extraction form. Extracted information included study characteristics (author, year, country, study design), patient demographics (sample size, age, sex), baseline disease severity (AHI), intervention details (duration), and outcome data (mean, standard deviation, and sample size for pre- and post-treatment values). Risk of bias assessment The methodological quality of the included studies was independently assessed by two reviewers, with any disagreements resolved by consensus. To ensure strict methodological rigor and adherence to current systematic review guidelines, the risk of bias was evaluated using design-specific tools rather than a unified framework. Specifically, the Cochrane Risk of Bias 2 (RoB 2) tool was applied to the randomized controlled trials (RCTs) [19]. For the non-randomized controlled trial (NRCT), the Risk of Bias in Non-randomized Studies - of Interventions (ROBINS-I) tool ed [20]. Finawas utilizlly, the five-case series, which inherently lack a control group, were evaluated using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case Series. The assessment results were subsequently visualized as a multi-panel figure using the ggplot2 package in R. Data synthesis and statistical analysis The primary outcome was the change in AHI, expressed as the Mean Difference (MD) with 95% Confidence Intervals (CIs). The meta-analysis was performed using the meta package in R (version 4.2.2). Given the anticipated clinical and methodological diversity across studies, a random-effects model with the Restricted Maximum-Likelihood (REML) estimator was used for all analyses. Statistical heterogeneity was quantified using the I² statistic, where values of 25%, 50%, and 75% were considered as low, moderate, and high heterogeneity, respectively. A prediction interval was also calculated to estimate the range of true effects in future studies [21]. We qualitatively compared the effect estimates reported in randomized controlled trials versus non-randomized studies to assess potential sources of heterogeneity. Sensitivity analyses were conducted by omitting studies with a high risk of bias to assess the robustness of the results. A leave-one-out influence analysis was performed to evaluate the impact of individual studies on the overall pooled estimate. A p-value < 0.05 was considered statistically significant. Following the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions, neither a visual assessment of a funnel plot nor formal quantitative tests (such as Egger’s test) were performed to assess publication bias, as the number of included studies in the meta-analysis was fewer than 10. Result Literature search and study selection The initial database search yielded a total of 461 records. After removing 153 duplicates, 308 records remained. A further 142 records were excluded by automation tools for various reasons. The remaining 166 records were screened based on their titles and abstracts, which led to the exclusion of 155 records primarily due to irrelevant topics (n = 72), incorrect population (e.g., adult studies) (n = 42), or wrong publication type (e.g., reviews, editorials) (n = 41). Consequently, 11 full-text articles were assessed for eligibility. Of these, three articles were excluded for the following reasons: two studies did not report relevant respiratory outcomes (e.g., AHI or airway volume), and one was a review article with no original data. Finally, a total of 8 studies met the inclusion criteria and were included in this systematic review and meta-analysis [22–29]. The detailed selection process is illustrated in the PRISMA 2020 flow diagram (Fig. 1). PRISMA 2020 flow diagram for the systematic review Characteristics of included studies and risk of bias The eight included studies, published between 2010 and 2025, comprised a total of 259 pediatric patients. The characteristics of these studies are summarized in Table 1. The included literature consisted of two randomized controlled trials (RCTs), one non-randomized controlled trial (NRCT), and five case series. The primary outcome measure in seven of the eight studies was the Apnea-Hypopnea Index (AHI), while one RCT focused on changes in oropharyngeal airway volume. Table 1Characteristics of included studies Characteristics of included studies The risk of bias assessment for the included studies was conducted using design-specific tools to ensure methodological rigor, and the results are presented in Fig. 2. Overall, the methodological quality of the evidence was varied. The two RCTs ([24]; Radwan et al., 2023), evaluated using the Cochrane RoB 2 tool, were judged to have a low overall risk of bias, indicating high methodological quality for their study design (Fig. 2A). The non-randomized controlled trial [27], assessed via the ROBINS-I tool, presented a moderate to serious risk of bias, primarily driven by the inherent risks of confounding and participant selection bias typical of non-randomized designs (Fig. 2B). Finally, the five-case series, evaluated using the JBI Critical Appraisal Checklist, generally met the methodological criteria for their specific study design. However, their evidence level is inherently limited by the absence of a control group, and several of these studies lacked clarity regarding the consecutive inclusion of participants, raising some concerns about selection bias (Fig. 2C). Risk of bias assessments for the included studies utilizing design-specific tools. (A) Risk of bias summary for Randomized Controlled Trials (RCTs) evaluated using the Cochrane RoB 2 tool. (B) Risk of bias summary for the Non-Randomized Controlled Trial (NRCT) evaluated using the ROBINS-I tool. (C) Critical appraisal summary for Case Series evaluated using the Joanna Briggs Institute (JBI) Checklist for Case Series. Legend: Green (+) indicates "Low risk of bias" or "Yes" (methodological criteria met); Yellow (!) indicates "Some concerns", "Moderate risk", or "Unclear"; Red (x) indicates "High/Seriou’s risk of bias" or "No" (methodological criteria not met). Note: To ensure methodological rigor and adhere to current systematic review guidelines, the included studies were assessed using distinct tools strictly appropriate for their specific study designs, avoiding the misapplication of a single unified framework Main efficacy of twin-block on apnea-hypopnea index (AHI) A meta-analysis of seven studies that reported AHI as an outcome was conducted. The random-effects model showed that treatment with the Twin-Block appliance resulted in a statistically significant and clinically meaningful reduction in OSA severity. The pooled Mean Difference (MD) was − 6.68 (95% Confidence Interval [CI]: -8.76 to -4.60; p < 0.0001). The forest plot summarizing this meta-analysis is presented in Fig. 3. However, significant heterogeneity was observed among the studies (I² = 89.1%, p < 0.001). Forest plot of the meta-analysis for the change in Apnea-Hypopnea Index (AHI) Anatomical evidence from high-quality RCT The RCT by Radwan et al. (2023) could not be included in the primary AHI meta-analysis as it utilized oropharyngeal airway volume as its primary outcome instead of the AHI, thus its data were not poolable with the other studies. However, it provided crucial anatomical evidence. The study demonstrated that, compared to a control group, the Twin-Block appliance led to a significant increase in oropharyngeal airway volume. Sensitivity and influence analyses Sensitivity analyses were conducted to assess the robustness of the results by excluding studies with high susceptibility to bias. For this analysis, ‘low-quality studies’ were explicitly defined as retrospective case series with small sample sizes (n < 25) or studies that lacked appropriate baseline controls [23, 25], which corresponds to a higher risk of selection bias identified in the JBI critical appraisal, specifically regarding the lack of clear consecutive inclusion. The result remained consistent and statistically significant (MD = -7.14, 95% CI: -9.93 to -4.35), confirming that the overall conclusion was not driven by lower-quality evidence (Fig. 4A). Furthermore, a leave-one-out influence analysis was conducted. As shown in Fig. 4B, omitting any single study did not substantially alter the pooled effect estimate or its statistical significance, which further strengthens the stability of our results. Sensitivity and influence analyses for the meta-analysis of AHI change. A) Forest plot of the sensitivity analysis: This analysis was performed after excluding two studies [23, 25] with the lowest quality scores. The pooled estimate remains statistically significant, indicating the robustness of the primary finding. B) Leave-one-out influence analysis: The plot shows the pooled mean difference and 95% confidence interval for the meta-analysis when each study is omitted one at a time. The overall pooled estimate (bottom line) is shown for comparison. The results demonstrate that no single study disproportionately influences the overall conclusion Assessment of publication bias As the meta-analysis included fewer than 10 studies, a formal assessment of publication bias was not conducted, as tests for funnel plot asymmetry would lack sufficient statistical power to distinguish chance from real asymmetry [30]. The plot shows the mean difference (MD) in AHI (events/hour) for each individual study and the pooled estimate from the random-effects model. The squares represent the point estimate of the effect for each study, with the size of the square proportional to the study’s weight in the analysis. The horizontal lines represent the 95% confidence intervals (CI). The diamond represents the pooled mean difference and its 95% CI. Heterogeneity statistics (I² and p-value) are also presented. Discussion Principal findings in context This systematic review and meta-analysis synthesize the most current body of evidence, incorporating eight clinical studies, to evaluate the efficacy of the Twin-Block appliance in managing pediatric OSA. Our primary finding demonstrates that this intervention leads to a statistically significant and clinically impactful mean reduction in the Apnea-Hypopnea Index of approximately 6.7 events/hour. This result not only confirms but substantially strengthens the preliminary findings of the previous review by Duan et al., by incorporating novel, high-quality evidence. The robustness of this conclusion is underscored by our sensitivity analysis, which showed that the effect estimate remained stable even after the exclusion of studies with a higher risk of bias. Deconstructing heterogeneity: insights from study design comparison and high-quality evidence A salient feature of the current body of literature, and a key finding of our analysis, is the profound inter-study heterogeneity (I² > 89%). This is unsurprising, given the amalgamation of diverse study designs, from case series to RCTs. While this heterogeneity complicates the interpretation of the pooled estimate from the overall analysis, it simultaneously highlights the critical importance of distinguishing between study designs. First, differences in study design contribute substantially. Our analysis pooled data from rigorous RCTs alongside retrospective case series; the latter are inherently more prone to selection bias and may overestimate treatment effects due to the lack of control groups. Second, variability in baseline disease severity is a critical source of heterogeneity. The included studies recruited populations ranging from very mild OSA to moderate-severe cases. Since the magnitude of AHI reduction is often proportional to baseline severity, this variance naturally inflates statistical heterogeneity. Third, there is a lack of standardization regarding the intervention itself. Differences in Twin-Block construction and wear protocols likely influence the treatment magnitude. Finally, the study populations varied regarding prior or combined treatments, such as whether patients were treatment-naïve or had persistent OSA following adenotonsillectomy. Importantly, while this statistical heterogeneity warrants caution regarding the precise magnitude of the effect and limits broad generalizability, it does not negate the consistency of the therapeutic signal observed across studies. Despite these variations, the direction of effect remained uniform, with Twin-Block therapy consistently associated with a reduction in OSA severity. Our qualitative synthesis and quantitative analysis of the included RCTs provide the most reliable insights. The crossover RCT by Idris et al. suggested a modest and non-significant effect, a finding likely attributable to the study’s small sample size and the low baseline AHI of its participants. In stark contrast, the parallel-group RCT by Radwan et al., although not quantitatively poolable with the AHI studies, offers compelling mechanistic support. It provides Level 1 evidence that the Twin-Block appliance induces a significant increase in oropharyngeal airway volume compared to a control group. When viewed together, the evidence from the RCTs suggests a coherent narrative: the Twin-Block appliance effectuates a tangible anatomical expansion of the upper airway, which, in patient populations with a sufficient degree of baseline obstruction, translates into a clinically significant reduction in respiratory events. The overall pooled estimate of -6.7 events/hour, therefore, likely represents a conservative average of this effect across a spectrum of patient severities and study designs [31]. Clinical and mechanistic implications The findings of this review have direct clinical implications. For the growing subpopulation of children with OSA where mandibular retrognathia is a primary etiological driver, the Twin-Block appliance should be considered a first-line, non-invasive therapeutic modality, either as a standalone treatment or as an adjunct to adenotonsillectomy [32]. The magnitude of AHI reduction observed is comparable to that reported for other interventions, positioning the Twin-Block as a potent tool in the clinician’s armamentarium. Mechanistically, our synthesis supports the hypothesis that the appliance’s efficacy is rooted in its orthopedic capacity to modify craniofacial growth. By stimulating mandibular advancement, it physically enlarges the retrolingual space, mitigating the anatomical predisposition to pharyngeal collapse [33, 34]. This stands in contrast to therapies that target only soft tissue (like T&A) or provide pneumatic splinting (like CPAP), offering a unique approach that aims to correct the underlying skeletal framework [35]. To improve clinical decision-making, we propose specific candidate profiles based on the current evidence [36]. The ideal candidates for Twin-Block therapy are prepubertal or pubertal children presenting with mild-to-moderate OSA concomitant with a skeletal Class II malocclusion due to mandibular retrognathia [37]. Furthermore, this appliance may serve as a valuable salvage therapy for children with residual OSA following adenotonsillectomy, or as an alternative for those who are intolerant or non-adherent to CPAP, provided that a craniofacial discrepancy remains a contributing factor. Limitations and strengths of the evidence base The primary strength of this review lies in its comprehensive and updated search, and its rigorous, multi-faceted analytical approach, including subgroup and sensitivity analyses to dissect heterogeneity. However, the conclusions must be interpreted in the context of the limitations of the primary literature. Despite being an updated analysis, the number of eligible RCTs remains limited to two. While the inclusion of recent high-quality trials, particularly the study, provides critical mechanistic validation regarding airway volume and improves the overall quality compared to previous reviews, it does not fully resolve the historical limitations of the evidence base. Consequently, the overall certainty of the evidence regarding AHI reduction should be regarded as moderate rather than high. The evidences base is still numerically dominated by non-randomized studies. As highlighted by our rigorous application of design-specific risk of bias tools (ROBINS-I and JBI), these observational studies are inherently susceptible to selection bias and confounding due to the lack of randomization and appropriate control groups [38]. Furthermore, there is a conspicuous paucity of standardized patient-centered outcomes in the existing literature. While AHI is the standard physiological metric for OSA severity, it does not fully capture the clinical burden of the disease or the tangible benefits of treatment [39]. Critical domains such as neurocognitive performance, behavioral regulation, daytime symptoms, and quality of life were largely underrepresented across the included studies [12]. Consequently, relying solely on AHI may result in an incomplete assessment of therapeutic efficacy. This represents a critical evidence gap; future high-quality RCTs must prioritize these validated, multi-dimensional outcome measures to determine if the physiological improvements driven by the Twin-Block translate into meaningful enhancements in a child’s daily functioning. Crucially, the current evidence base is limited by a lack of long-term follow-up data. Given that the Twin-Block is a growth-modifying intervention, questions regarding the durability of its treatment effects remain unanswered. Specifically, there is insufficient evidence concerning the stability of AHI improvement over time, the post-treatment craniofacial growth trajectory, and the risk of relapse or persistence of OSA into adulthood. This represents a significant gap in knowledge, and future longitudinal trials are urgently needed to determine if the short-term structural changes translate into a permanent resolution of the condition. Finally, due to the limited number of eligible studies (n < 10), we were unable to formally evaluate publication bias using funnel plots or Egger’s tests. The potential presence of publication bias, wherein smaller studies with non-significant effects might remain unpublished, cannot be entirely ruled out and remains a limitation of the current evidence base. Conclusions and directives for future research In conclusion, this systematic review and meta-analysis provides strengthened, updated evidence that the Twin-Block appliance is an effective treatment for reducing the severity of OSA in appropriately selected children. While the overall quality of the available literature is still evolving, the signal of therapeutic efficacy is consistent and robust. To definitively establish the role of this therapy, the field requires large-scale, multicenter RCTs with long-term follow-up. Future trials must adhere to standardized reporting guidelines, employ validated, multi-dimensional outcome measures (including polysomnography, quality of life, and neurocognitive assessments), and ideally, compare the Twin-Block not only to no treatment but also head-to-head against other modalities like T&A or CPAP [40]. Such research will be pivotal in refining clinical guidelines and optimizing personalized treatment pathways for children with obstructive sleep apnea. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Authors’ contributions X.Z. conceived the study, designed the protocol, performed the literature search, data extraction, statistical analysis, and wrote the original manuscript draft. F.W. and M.F. participated in the literature search, data extraction, and risk of bias assessment. D.Y. and Z.C. assisted with the statistical analysis and data interpretation. C.H. supervised the entire project, acquired funding, and critically reviewed and edited the manuscript for intellectual content. All authors read and approved the final manuscript. Funding This work was supported by the Hainan Province Science and Technology Special Fund (grant numbers ZDYF2022SHFZ017 and ZDYF2019216) and the Higher Education Teaching Reform Research Project of Hainan Province (grant number Hnjg2023ZD-29). Data availability All data generated or analyzed during this study are included in this published article. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Not applicable. This study is a systematic review and meta-analysis of previously published literature and does not involve any new studies with human participants or animals performed by any of the authors. Consent for publication Not applicable. This study does not contain any individual person’s data in any form. Competing interests The authors declare that they have no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement All data generated or analyzed during this study are included in this published article. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.